Evidence map›Paper›PMID 39700280›Full record

ArticleScience (New York, N.Y.)2024

Cellular RNA interacts with MAVS to promote antiviral signaling.

Nandan S Gokhale, Russell K Sam, Kim Somfleth, Matthew G Thompson, Daphnée M Marciniak, Julian R Smith, Emmanuelle Genoyer, Julie Eggenberger, Lan H Chu, Moonhee Park and 6 more

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Innate immunity: current understandings and future perspectives.Signal transduction and targeted therapy · 2026
    Review
  2. Antiviral immunity regulates cnidarian viriomes.Nature ecology & evolution · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Regulation of Innate Immune Signaling by Autophagy.International journal of molecular sciences · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Role of autophagy in antiviral innate immunity.Cellular & molecular biology letters · 2026
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Nandan S GokhaleDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0002-4459-4053
Russell K SamDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0009-0005-5908-6077
Kim SomflethDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0002-9572-5172
Matthew G ThompsonDepartment of Integrative Immunobiology, Duke University, Durham, NC.ORCID 0000-0003-3813-9254
Daphnée M MarciniakDepartment of Pharmacology, University of Washington, Seattle, WA.ORCID 0009-0002-4830-8365
Julian R SmithDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0002-8167-4335
Emmanuelle GenoyerDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0002-3879-4366
Julie EggenbergerDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0003-1410-4399
Lan H ChuDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0002-0378-6614
Moonhee ParkDepartment of Integrative Immunobiology, Duke University, Durham, NC.ORCID 0009-0009-5489-8390
Steve DvorkinDepartment of Immunology, University of Washington, Seattle, WA.
Andrew OberstDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0002-9500-7912
Stacy M HornerDepartment of Integrative Immunobiology, Duke University, Durham, NC.ORCID 0000-0002-9351-7409
Shao-En OngDepartment of Pharmacology, University of Washington, Seattle, WA.ORCID 0000-0003-3314-5903
Michael GaleDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0002-6332-7436
Ram SavanDepartment of Immunology, University of Washington, Seattle, WA.ORCID 0000-0002-3087-1355

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
Defining the role of the RNA modification N6-methyladenosine in the hepatitis C virus lifecycleR01AI125416 · NIAID · DUKE UNIVERSITY · PI Stacy Michelle Horner · 2016 to 2026
$5.5M
Innate Immune Regulation of Zika Virus InfectionR01AI145296 · NIAID · UNIVERSITY OF WASHINGTON · PI COYNE, CAROLYN B, DIAMOND, MICHAEL S · 2019 to 2023
$4.1M
ZBP1 activationR01AI153246 · NIAID · UNIVERSITY OF WASHINGTON · PI OBERST, ANDREW ATWELL · 2021 to 2025
$3.1M
Prenylation in antiviral immunityR01AI175724 · NIAID · UNIVERSITY OF WASHINGTON · PI Ram Savan · 2023 to 2026
$2.5M
Regulation of RIG-I signaling and viral immune evasion by ufmylationR01AI155512 · NIAID · DUKE UNIVERSITY · PI HORNER, STACY MICHELLE · 2021 to 2025
$2.3M
Supplement to DEFINING PATHWAY-SPECIFIC KINASE SIGNALING MODULES WITH PROTEOMICSR01GM129090 · NIGMS · UNIVERSITY OF WASHINGTON · PI ONG, SHAO-EN · 2019 to 2022
$1.7M
A NanoLC-Orbitrap Tribrid Instrument for Comprehensive Proteomics AnalysesS10OD021502 · OD · UNIVERSITY OF WASHINGTON · PI ONG, SHAO-EN · 2017 to 2017
$906k
Regulation of cardiomyocyte inflammation during viral infectionR21AI141823 · NIAID · UNIVERSITY OF WASHINGTON · PI SAVAN, RAM · 2020 to 2021
$507k
Host inflammatory response to SARS-CoV-2R21AI158788 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL · 2021 to 2022
$485k
The splicing factor CELF2 suppresses RNA ligands sensed by RIG-I-like receptorR21AI176442 · NIAID · UNIVERSITY OF WASHINGTON · PI SAVAN, RAM · 2023 to 2024
$485k
Regulation of the MAVS Signalosome by RNA and RNA-binding ProteinsK99AI175483 · NIAID · UNIVERSITY OF WASHINGTON · PI GOKHALE, NANDAN SATISH · 2023 to 2024
$231k
NIAID NIH HHS F32 AI176736NIAID NIH HHS K99 AI175483NIAID NIH HHS R01 AI125416NIAID NIH HHS R01 AI145296NIAID NIH HHS R01 AI153246NIAID NIH HHS R01 AI155512NIAID NIH HHS R01 AI175724NIAID NIH HHS R21 AI141823NIAID NIH HHS R21 AI158788NIAID NIH HHS R21 AI176442NIAID NIH HHS T32 AI007140NIGMS NIH HHS R01 GM129090NIH HHS S10 OD021502
6 · The paper itself

Abstract

Antiviral signaling downstream of RIG-I-like receptors (RLRs) proceeds through a multi-protein complex organized around the adaptor protein mitochondrial antiviral signaling protein (MAVS). Protein complex function can be modulated by RNA molecules that provide allosteric regulation or act as molecular guides or scaffolds. We hypothesized that RNA plays a role in organizing MAVS signaling platforms. We found that MAVS, through its central intrinsically disordered domain, directly interacted with the 3' untranslated regions of cellular messenger RNAs. Elimination of RNA by ribonuclease treatment disrupted the MAVS signalosome, including RNA-modulated MAVS interactors that regulate RLR signaling and viral restriction, and inhibited phosphorylation of transcription factors that induce interferons. This work uncovered a function for cellular RNA in promoting signaling through MAVS and highlights generalizable principles of RNA regulatory control of immune signaling complexes.

Indexed as

3' Untranslated RegionsAdaptor Proteins, Signal TransducingDEAD Box Protein 58Immunity, InnateRNA, MessengerVirus DiseasesAnimalsHEK293 CellsHumansInterferon Regulatory Factor-3MiceNIH 3T3 CellsPhosphorylationProtein DomainsReceptors, ImmunologicSignal Transduction3' Untranslated RegionsAdaptor Proteins, Signal TransducingDEAD Box Protein 58Interferon Regulatory Factor-3IRF3 protein, humanMAVS protein, humanReceptors, ImmunologicRIGI protein, humanRNA, Messenger

Identifiers

PMID39700280
PMCPMC11905950

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.